Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Ductal Adenocarcinoma 1Colorectal Neoplasms 1Anus Neoplasms 1Acute Graft Versus Host Disease 1

Interventions

Pancreaticoduodenectomy 2titanium silicide 1tislelizumab 1sonidegib 1paricalcitol 1mitazalimab 1lenvatinib 1ivosidenib 1irinotecan sucrosofate 1glucoraphanin 1devimistat 1Transurethral Resection of Prostate 1Tissue Banks 1Specimen Handling 1Saline Solution 1S 1 (combination) 1Ropivacaine 1Robotic Surgical Procedures 1Radiomics 1Positron Emission Tomography Computed Tomography 1Parturition 1PEGPH20 1Oxaliplatin 1Neoadjuvant Therapy 1Magnetic Resonance Spectroscopy 1Losartan 1Irinotecan 1Immunotherapy 1Hydroxychloroquine 1Glucose 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Pancreatic Ductal Adenocarcinoma × Parturition × Clear all
NCT04975217 2026-05-22

Fecal Microbial Transplants for the Treatment of Pancreatic Cancer

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Suspended
10 enrolled
Gastrointestinal

Pancreatic Ductal Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡